naut: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	113	113
Net decrease in cash, cash equivalents and restricted cash	-3,771	6,811
Cash and cash equivalents at beginning of period	28,648	-
Cash and cash equivalents at end of period	24,877	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	113	113
Net decrease in cash, cash equivalents and restricted cash	-3,771	6,811
Cash and cash equivalents at beginning of period	28,648	-
Cash and cash equivalents at end of period	24,877	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Nautilus Biotechnology, Inc. (NAUT)